This will cement the Japanese pharmaceutical company’s position as the 2nd major shareholder in DHG Pharma.
The SaaS technology company will use the funds to expand market outreach and establish a stronger presence in Southeast Asia.
Babytree will use the IPO proceeds to fund expansion projects, research & development, as well as future investments including acquisition and strategic alliance.
Koufu plans to start trading on July 18th and use the proceeds to fund integrated facility, revamps, and growth.
The investment will be used to fund loan capital as well as to enhance its proprietary technology platform, underwriting and the development of new products.
Propell Asia will be a regional accelerator focusing on property technology (proptech) startups in Southeast Asia.